Santini J - Search Results

1

[Optimization using the pharmacokinetics of the therapeutic index of CDDP-5 FU treatment over 5 continuous days].

Milano G, Santini J, Thyss A, Reneè N, Veins P, Chauvel P, Schneider M, Demard F. Milano G, et al. Among authors: santini j. Bull Cancer. 1989;76(8):905-8. Bull Cancer. 1989. PMID: 2620123 French. No abstract available.

2

Dose reduction without loss of efficacy for 5-fluorouracil and cisplatin combined with folinic acid. In vitro study on human head and neck carcinoma cell lines.

Etienne MC, Bernard S, Fischel JL, Formento P, Gioanni J, Santini J, Demard F, Schneider M, Milano G. Etienne MC, et al. Among authors: santini j. Br J Cancer. 1991 Mar;63(3):372-7. doi: 10.1038/bjc.1991.88. Br J Cancer. 1991. PMID: 2003979 Free PMC article.

3

Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas.

Demard F, Chauvel P, Santini J, Vallicioni J, Thyss A, Schneider M. Demard F, et al. Among authors: santini j. Head Neck. 1990 May-Jun;12(3):225-31. doi: 10.1002/hed.2880120306. Head Neck. 1990. PMID: 2358333

4

Salivary passage of 5-fluorouracil during continuous infusion.

Milano G, Thyss A, Santini J, Frenay M, Francois E, Schneider M, Demard F. Milano G, et al. Among authors: santini j. Cancer Chemother Pharmacol. 1989;24(3):197-9. doi: 10.1007/BF00300243. Cancer Chemother Pharmacol. 1989. PMID: 2736710

5

5-FU therapeutic monitoring with dose adjustment leads to an improved therapeutic index in head and neck cancer.

Santini J, Milano G, Thyss A, Renee N, Viens P, Ayela P, Schneider M, Demard F. Santini J, et al. Br J Cancer. 1989 Feb;59(2):287-90. doi: 10.1038/bjc.1989.59. Br J Cancer. 1989. PMID: 2930694 Free PMC article.

6

[Induction chemotherapy with cisplatin-5 fluorouracil. Current results in cervicofacial carcinology].

Demard F, Schneider M, Chauvel P, Ramaioli A, Vallicioni J, Santini J. Demard F, et al. Among authors: santini j. Ann Otolaryngol Chir Cervicofac. 1987;104(6):399-406. Ann Otolaryngol Chir Cervicofac. 1987. PMID: 3426053 French.

7

[EGF receptor, a prognostic factor in epidermoid cancers of the upper aerodigestive tracts].

Formento JL, Francoual M, Ramaioli A, Dassonville O, Santini J, Demard F, Schneider M, Milano G. Formento JL, et al. Among authors: santini j. Bull Cancer. 1994 Jul;81(7):610-5. Bull Cancer. 1994. PMID: 7742604 French.

8

Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas.

Santini J, Formento JL, Francoual M, Milano G, Schneider M, Dassonville O, Demard F. Santini J, et al. Head Neck. 1991 Mar-Apr;13(2):132-9. doi: 10.1002/hed.2880130209. Head Neck. 1991. PMID: 2022478

9

[Intra-arterial chemotherapy of ORL cancer. Value of an implantable infusion system and scintigraphic monitoring].

Santini J, Dassonville O, Serra C, Falewee MN, Darcourt J, Schneider M, Demard F. Santini J, et al. Ann Otolaryngol Chir Cervicofac. 1989;106(8):557-60. Ann Otolaryngol Chir Cervicofac. 1989. PMID: 2619159 French.

10

The labelling index: a prognostic factor in head and neck carcinoma.

Chauvel P, Courdi A, Gioanni J, Vallicioni J, Santini J, Demard F. Chauvel P, et al. Among authors: santini j. Radiother Oncol. 1989 Mar;14(3):231-7. doi: 10.1016/0167-8140(89)90171-0. Radiother Oncol. 1989. PMID: 2710954

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

401 results

Search Page

Filters